Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-1994 | 04-1994 | 01-1994 | 10-1993 | 07-1993 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 4,548 | 4,281 | 3,580 | 3,714 | 3,258 |
| TOTAL | $4,548 | $4,281 | $3,580 | $3,714 | $3,258 |
| Non-Current Assets | |||||
| PPE Net | 13,473 | 11,050 | 10,495 | 10,098 | 8,931 |
| Other Non-Current Assets | 4,329 | 4,394 | 4,428 | 4,417 | 4,315 |
| TOTAL | $17,802 | $15,444 | $14,923 | $14,515 | $13,246 |
| Total Assets | $22,350 | $19,725 | $18,503 | $18,229 | $16,504 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,723 | 6,670 | 7,979 | 8,117 | 7,965 |
| Accrued Expenses | 4,196 | 3,772 | 3,830 | 3,920 | 3,353 |
| TOTAL | $22,611 | $17,345 | $31,934 | $27,710 | $17,383 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 728 | 757 | 783 | 813 | 840 |
| TOTAL | $2,232 | $2,269 | $2,300 | $2,486 | $2,471 |
| Total Liabilities | $24,843 | $19,614 | $34,234 | $30,196 | $19,854 |
| Shareholders' Equity | |||||
| Common Shares | 54 | 54 | 54 | 54 | 54 |
| Other shareholders' equity | -7,300 | -7,397 | -7,520 | -7,608 | -7,656 |
| TOTAL | $16,428 | $16,331 | $16,188 | $16,100 | $16,052 |
| Total Liabilities And Equity | $41,271 | $35,945 | $50,422 | $46,296 | $35,906 |